News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Michael T. Halpern, MD, PhD

Articles by Michael T. Halpern, MD, PhD

Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and Cost

ByL. Clark Paramore, MSPH,Michael T. Halpern, MD, PhD,Pablo Lapuerta, MD,Judith S. Hurley, MS, RD,Floyd J. Frost, PhD,David G. Fairchild, MD, MPH

April 1st 2001

A Pharmacoeconomic Analysis of Rimelolone for the Treatment of Ophthalmic Inflammatory Conditions

ByMichael T. Halpern, MD, PhD,Cynthia S. Palmer, MSc,C. Stephen Foster, MD,Ashish Pal, BS Pharm, MBA,Carmelina Battista, PharmD

June 1st 1998

Modeling the Cost-Effectiveness of Oral Therapy for Nail Fungus

ByMichael T. Halpern, MD, PhD,Cynthia Palmer, MSc

January 1st 1996

Latest Updated Articles

A Pharmacoeconomic Analysis of Rimelolone for the Treatment of Ophthalmic Inflammatory Conditions
June 1st 1998
Modeling the Cost-Effectiveness of Oral Therapy for Nail Fungus
January 1st 1996
Impact of Poorly Controlled Hypertension on Healthcare Resource Utilization and Cost
April 1st 2001

Trending on AJMC

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning

ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM

Framework Charts a 3-Stage Path to Catch Psoriatic Arthritis Early

Early Secukinumab Sustains Psoriasis Clearance a Year After Stopping